Atopic Dermatitis in the Modern Era Assessing Patient Outcomes and Economic Burden
A Q&A with Brad P. Glick, DO, MPH, FAAD
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Transforming care through social determinants of health
2
Why MASH patients need a clearer path forward
3
Prior authorization isn't broken. It's unmeasured
4
FDA approves Lumvoa, first TED therapy labeled for both active and chronic disease
5